PressSeptember 11, 2026 Strata Mental Health Solutions Awarded U.S. Healthcare Provider Training Grant from Compass Pathways to Develop Provider Training for COMP360
PressSeptember 11, 2026 Quantum BioPharma Ltd. (NASDAQ: QNTM) Filling Key Gap in MS Treatment, Cleared by FDA to Launch Historic Trials
PressSeptember 10, 2026 Fluence Selected by Compass Pathways to Develop Post-Approval COMP360 Provider Training
PressSeptember 10, 2026 Definium Therapeutics to Present Topline Data from Phase 3 Emerge and Voyage Trials Across Major Depressive Disorder and Generalized Anxiety Disorder at Psych Congress 2026
PressSeptember 10, 2026 Compass Pathways Announces U.S. Grant Program Recipients for the Development of Post-Approval COMP360 Provider Training
PressSeptember 10, 2026 Compass Pathways to Participate in Investor Conferences the Week of September 14th
PressSeptember 9, 2026 Quantum BioPharma Ltd. NASDAQ: QNTM) Receives FDA Clearance to Begin Trials for Historic MS Treatment
PressSeptember 9, 2026 Compass Pathways’ New 52-Week Topline Open-Label Data from Phase 3 COMP005 Trial Demonstrates Additional Benefit from Another COMP360 Dose in Part C Extending Durability Out to 1 Year
PressSeptember 8, 2026 Definium Therapeutics Receives Breakthrough Therapy Designation for DT120 (lysergide) Orally Disintegrating Tablet (ODT) in Major Depressive Disorder (MDD) Following Positive Phase 3 Results
PressSeptember 8, 2026 Compass Pathways to Debut U.S. HCP Education Campaign and Present New HEOR Data at Psych Congress 2026
PressSeptember 3, 2026 Compass Pathways Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
PressSeptember 3, 2026 Pasithea Therapeutics Announces Participation in Two September 2026 Investor Conferences
PressSeptember 1, 2026 Quantum BioPharma Announces Plans to Voluntarily Delist its Class B Shares from the Canadian Securities Exchange
PressSeptember 1, 2026 Enveric Biosciences to Present at H.C. Wainwright 28th Annual Global Investment Conference
PressSeptember 1, 2026 Relmada Therapeutics to Participate at the Wells Fargo 21st Annual Healthcare Conference
PressSeptember 1, 2026 Compass Pathways to Participate in 2026 Cantor Global Healthcare Conference on September 9, 2026
PressAugust 31, 2026 SciSparc: Subsidiary NeuroThera Labs Achieves Significant Enrollment Momentum in SCI‑210 Autism Clinical Trial
PressAugust 26, 2026 SciSparc Advances Agentic AI Strategy with Addition of Internationally Recognized AI Expert Prof. Carmel Domshlak to Scientific Advisory Board
PressAugust 26, 2026 Definium Therapeutics to Participate at Upcoming Investor Conferences and Events
PressAugust 24, 2026 SciSparc: NeuroThera-Clearmind Collaboration Advances MDMA-N-acylethanolamines IP for the Treatment of PTSD Amid Rising U.S. Federal Support for Psychedelic Innovation
